EUropean Scleroderma Trials And Research group
EUSTAR actively encourages and supports the development and conducting of clinical and basic science research in systemic sclerosis
Who we are
The European Scleroderma Trials and Research group (EUSTAR) aims to foster the awareness, understanding and research on systemic sclerosis and its management throughout Europe and the rest of the world.
EUSTAR is an international scleroderma research network acting under the umbrella of the World Scleroderma Foundation. The aim is to coordinate and focus research activities, in order to improve treatment, quality of life and prognosis of patients with scleroderma. The EUSTAR group was launched in 2004 and was initially supported by the European League Against Rheumatism (EULAR). The main research tool is a multicenter online database that allows following prospectively more than 15,000 patients with scleroderma in more than 200 International centres. Each patient’s annually scheduled visit for medical purposes is recorded providing longitudinal observational data. Any contributing team can submit a research project and get access to the whole database for the specific approved project.